(2019). Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: A cost-effectiveness analysis.
Chicago Style (17th ed.) CitationAdvantage of Inhaled Corticosteroids as Additional Therapy to Systemic Corticosteroids for Pediatric Acute Asthma Exacerbations: A Cost-effectiveness Analysis. 2019.
MLA (8th ed.) CitationAdvantage of Inhaled Corticosteroids as Additional Therapy to Systemic Corticosteroids for Pediatric Acute Asthma Exacerbations: A Cost-effectiveness Analysis. 2019.
Warning: These citations may not always be 100% accurate.